{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:54:08Z","timestamp":1788339248311,"version":"build-2803163510"},"reference-count":43,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Objectives: This study aimed to investigate the association between nonalcoholic fatty liver disease (NAFLD), assessed by the Fatty Liver Index (FLI), and the occurrence of lung abscess within a large population-based cohort. Method: We conducted a nationwide retrospective study using data from 367,930 subjects who underwent National Health check-ups between 2009 and 2018. Cox proportional hazards regression was performed to evaluate the association between the FLI and the incidence of lung abscess and community-acquired pneumonia (CAP) after adjusting for age, sex, and relevant covariates. Results: Among the study population, 455 (0.12%) and 44,934 (12.2%) patients were diagnosed with lung abscesses and CAP, respectively. The cumulative incidence of lung abscess was higher in individuals with elevated FLI values (FLI &lt; 30, 0.10%; 30 \u2264 FLI &lt; 60, 0.16%; FLI \u2265 60, 0.18%; p &lt; 0.001), whereas the incidence of CAP decreased across FLI groups (FLI &lt; 30, 12.4%; 30 \u2264 FLI &lt; 60, 12.3%; FLI \u2265 60, 11.0%; p &lt; 0.001). After adjusting for covariates, the risk of lung abscess significantly increased in the 30 \u2264 FLI &lt; 60 (Hazard ratio (HR) = 1.26; 95% confidence interval (CI), 0.95\u20131.68; p = 0.115) and the FLI \u2265 60 (HR = 1.67; 95% CI, 1.37\u20132.29; p &lt; 0.001) groups, although the risk of CAP was relatively small in both groups (30 \u2264 FLI &lt; 60; HR = 1.06; 95% CI, 1.03\u20131.09; p &lt; 0.001) (FLI \u2265 60; HR = 1.13; 95% CI, 1.08\u20131.12; p &lt; 0.001). Conclusions: Our study provides compelling evidence supporting a potential link between NAFLD, as measured by FLI, and the incidence of lung abscess. These findings suggest the importance of vigilant monitoring of respiratory health in patients with NAFLD and emphasise the need for early detection of possible complications.<\/jats:p>","DOI":"10.3390\/jcm14020542","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T06:46:10Z","timestamp":1737009970000},"page":"542","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nonalcoholic Fatty Liver Disease Increases the Risk of Lung Abscess: Findings from a Nationwide Cohort Study"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0806-1427","authenticated-orcid":false,"given":"Eunso","family":"Lee","sequence":"first","affiliation":[{"name":"Division of Allergy and Pulmonology, Department of Internal Medicine, Chungnam National University Sejong Hospital, Sejong-si 30099, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0694-1579","authenticated-orcid":false,"given":"Jungok","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Chungnam National University Sejong Hospital, Sejong-si 30099, Republic of Korea"},{"name":"Department of Medicine, Chungnam National University School of Medicine, Deajeon 35015, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun-Young","family":"Yoon","sequence":"additional","affiliation":[{"name":"Division of Allergy and Pulmonology, Department of Internal Medicine, Chungnam National University Sejong Hospital, Sejong-si 30099, Republic of Korea"},{"name":"Department of Medicine, Chungnam National University School of Medicine, Deajeon 35015, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","article-title":"Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: A systematic review and meta-analysis","volume":"8","author":"Quek","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Krznari\u0107, J., and Vince, A. (2022). The role of non-alcoholic fatty liver disease in infections. Life, 12.","DOI":"10.3390\/life12122052"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Petrescu, M., Vlaicu, S.I., Cium\u0103rnean, L., Milaciu, M.V., M\u0103rginean, C., Florea, M., Vesa, C., and Popa, M. (2022). Chronic inflammation\u2014A link between nonalcoholic fatty liver disease (NAFLD) and dysfunctional adipose tissue. Medicina, 58.","DOI":"10.3390\/medicina58050641"},{"key":"ref_7","first-page":"198","article-title":"Association between non-alcoholic fatty liver disease and hospitalized patients with community-acquired pneumonia","volume":"19","author":"Nseir","year":"2017","journal-title":"Isr. Med. Assoc. J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/qjmed\/hcy227","article-title":"Non-alcoholic fatty liver disease and 30-day all-cause mortality in adult patients with community-acquired pneumonia","volume":"112","author":"Nseir","year":"2019","journal-title":"QJM"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Gjura\u0161in, B., Jeli\u010di\u0107, M., Kutle\u0161a, M., and Papi\u0107, N. (2022). The impact of nonalcoholic fatty liver disease on severe community-acquired pneumonia outcomes. Life, 13.","DOI":"10.3390\/life13010036"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"916","DOI":"10.4254\/wjh.v13.i8.916","article-title":"Association of non-alcoholic fatty liver disease and COVID-19: A literature review of current evidence","volume":"13","author":"Anirvan","year":"2021","journal-title":"World J. Hepatol."},{"key":"ref_11","unstructured":"GBD 2016 Lower Respiratory Infections Collaborators (2018). Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990\u20132016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect. Dis., 18, 1191\u20131210."},{"key":"ref_12","unstructured":"Mandell, L.A., Douglas, R.G., and Bennett, J.E. (2019). Principles and Practice of Infectious Diseases, Elsevier. [9th ed.]."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.chest.2023.08.020","article-title":"Epidemiology and clinical patterns of lung abscesses in ICU: A French multicenter retrospective study","volume":"165","author":"Bonny","year":"2024","journal-title":"Chest"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/0002-9343(78)90574-0","article-title":"Pharyngeal aspiration in normal adults and patients with depressed consciousness","volume":"64","author":"Huxley","year":"1978","journal-title":"Am. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1378\/chest.111.5.1266","article-title":"Quantitative aspiration during sleep in normal subjects","volume":"111","author":"Gleeson","year":"1997","journal-title":"Chest"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4082\/kjfm.22.0052","article-title":"Current status of the national health screening programs in South Korea","volume":"43","author":"Kang","year":"2022","journal-title":"Korean J. Fam. Med."},{"key":"ref_17","first-page":"e15","article-title":"Cohort Profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea","volume":"46","author":"Lee","year":"2017","journal-title":"Int. J. Epidemiol."},{"key":"ref_18","unstructured":"Health Insurance Review and Assessment Service, and National Health Insurance Service (2024, December 20). National Health Insurance Statistical Yearbook. 2020. NHISS. Available online: https:\/\/nhiss.nhis.or.kr\/bd\/ad\/bdada013cv.do."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.cgh.2012.12.031","article-title":"External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study","volume":"11","author":"Koehler","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e00042","DOI":"10.14309\/ctg.0000000000000042","article-title":"Role of fatty liver index and metabolic factors in the prediction of nonalcoholic fatty liver disease in a lean population receiving health checkup","volume":"10","author":"Hsu","year":"2019","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Yang, B.-L., Wu, W.-C., Fang, K.-C., Wang, Y.-C., Huo, T.-I., Huang, Y.-H., Yang, H.-I., Su, C.-W., Lin, H.-C., and Lee, F.-Y. (2015). External validation of fatty liver index for identifying ultrasonographic fatty liver in a large-scale cross-sectional study in Taiwan. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0120443"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Bedogni, G., Bellentani, S., Miglioli, L., Masutti, F., Passalacqua, M., Castiglione, A., and Tiribelli, C. (2006). The fatty liver index: A simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol., 6.","DOI":"10.1186\/1471-230X-6-33"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00535-017-1337-y","article-title":"A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease","volume":"52","author":"Kim","year":"2017","journal-title":"J. Gastroenterol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1007\/s10620-011-1736-5","article-title":"Fatty liver is associated with recurrent bacterial infections independent of metabolic syndrome","volume":"56","author":"Nseir","year":"2011","journal-title":"Dig. Dis. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Adenote, A., Dumic, I., Madrid, C., Barusya, C., Nordstrom, C.W., and Rueda Prada, L. (2021). NAFLD and infection, a nuanced relationship. Can. J. Gastroenterol. Hepatol., 5556354.","DOI":"10.1155\/2021\/5556354"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10096-019-03759-w","article-title":"Nonalcoholic fatty liver disease as a risk factor for Clostridioides difficile infection","volume":"39","author":"Vince","year":"2020","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e001224","DOI":"10.1136\/bmjgast-2023-001224","article-title":"Association of metabolic dysfunction-associated fatty liver disease with gastrointestinal infections: Insights from National Inpatient Sample Database","volume":"11","author":"Patel","year":"2024","journal-title":"BMJ Open Gastroenterol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1136\/gutjnl-2020-321611","article-title":"Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1016\/j.cgh.2023.05.013","article-title":"Risk of severe infection in patients with biopsy-proven nonalcoholic fatty liver disease\u2014A population-based cohort study","volume":"21","author":"Ebrahimi","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","article-title":"The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"16","author":"Kazankov","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1165\/rcmb.2014-0195OC","article-title":"The lung-liver axis: A requirement for maximal innate immunity and hepatoprotection during pneumonia","volume":"53","author":"Hilliard","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nrgastro.2016.85","article-title":"The role of the gut microbiota in NAFLD","volume":"13","author":"Leung","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","article-title":"Gut microbiota and human NAFLD: Disentangling microbial signatures from metabolic disorders","volume":"17","author":"Vigliotti","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"S248","DOI":"10.1093\/clinids\/16.Supplement_4.S248","article-title":"Anaerobic bacterial infections of the lung and pleural space","volume":"16","author":"Bartlett","year":"1993","journal-title":"Clin. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1086\/428574","article-title":"Changing bacteriology of adult community-acquired lung abscess in Taiwan: Klebsiella pneumoniae versus anaerobes","volume":"40","author":"Wang","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3748\/wjg.v29.i6.967","article-title":"Periodontal treatment and microbiome-targeted therapy in management of periodontitis-related nonalcoholic fatty liver disease with oral and gut dysbiosis","volume":"29","author":"Kuraji","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Kuchay, M.S., Mart\u00ednez-Montoro, J.I., Choudhary, N.S., Fern\u00e1ndez-Garc\u00eda, J.C., and Ramos-Molina, B. (2021). Non-alcoholic fatty liver disease in lean and non-obese individuals: Current and future challenges. Biomedicines, 9.","DOI":"10.3390\/biomedicines9101346"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cmi.2017.02.013","article-title":"Body mass index and the risk of infection\u2014From underweight to obesity","volume":"24","author":"Dobner","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Krznaric, J., Papic, N., Vrsaljko, N., Gjurasin, B., Kutlesa, M., and Vince, A. (2024). Steatotic liver disease and sepsis outcomes\u2014A prospective cohort study (SepsisFAT). J. Clin. Med., 13.","DOI":"10.3390\/jcm13030798"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2050312117745223","DOI":"10.1177\/2050312117745223","article-title":"Association between smoking and non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"6","author":"Rezayat","year":"2018","journal-title":"SAGE Open Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1445-5994.2011.02644.x","article-title":"Relationship between non-alcoholic fatty liver disease and pulmonary function","volume":"42","author":"Jung","year":"2012","journal-title":"Intern. Med. J."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/2\/542\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:29:53Z","timestamp":1759919393000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/2\/542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":43,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["jcm14020542"],"URL":"https:\/\/doi.org\/10.3390\/jcm14020542","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,16]]}}}